Export 14 results:
Author [ Title(Desc)] Type Year
Filters: Author is Graham, B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
A. T. Catanzaro, Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Gu, L., Martin, J. E., Novik, L., Chakrabarti, B. K., Butman, B., Gall, J., King, C., Andrews, C., Sheets, R., Gomez, P., Mascola, J., Nabel, G., Graham, B., and Team, T. Vaccine Re, Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 Candidate Vaccine Delivered by a Replication-Defective Recombinant Adenovirus Vector, J Infect Dis, vol. 194, pp. 1638-1649, 2006.
M. Crank, Gordon, I., Yamshchikov, G., Sitar, S., Hu, Z., Enama, M., Holman, L., Bailer, R., Pearce, M., Koup, R., Mascola, J., Nabel, G., Tumpey, T., Schwartz, R., Graham, B., Ledgerwood, J., and Team, T. V. R. C. 308 St, Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults, PLoS One, vol. 10, p. e0123969, 2015.
R. Belshe, Bolognesi, D., Clements, M., Corey, L., Fast, P., Graham, B., Keefer, M., Mestecky, J., Mulligan, M., Stablein, D., and Group, A. I. D. S. Vaccine Cl, Progress in HIV-1 Vaccine Development. Washington DC, 1995.
R. Seder, Chang, L., Enama, M., Zephir, K., Sarwar, U. N., Gordon, I., Holman, L., James, E., Billingsley, P., Gunasekera, A., Richman, A., Chakravarty, S., Manoj, A., Velmurugan, S., Li, M., ,, Sim, B., Ledgerwood, J., Graham, B., Hoffman, S., and Team, T. V. R. C. 312 St, Protection Against Malaria by Intravenous Immunization With A Non-Replicating Sporozoite Vaccine, Science, vol. 341, pp. 1359-1365, 2013.
S
U. Sarwar, Costner, P., Enama, M., Berkowitz, N., Hu, Z., Hendel, C., Sitar, S., Plummer, S., Mulangu, S., Bailer, R., Koup, R., Mascola, J., Nabel, G., Sullivan, N., Graham, B., Ledgerwood, J. E., and Team, T. V. R. C. 206 St, Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial, J Infect Dis, vol. 211, pp. 549-557, 2015.
W. Jaoko, Kayitenkore, K., G Manyonyi, O., Karita, E., Schmidt, C., Fast, P., Komaroff, W., Cooper, A., Boaz, M., Gilmour, J., Dally, L., Ho, M., Smith, C., and Graham, B., Safety and Immunogenicity of VRC Multiclade HIV-1 Adenoviral Vector Vaccine Alone or with VRC Multiclade HIV-1 DNA Plasmid Vaccine in the African Adults, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
W. Jaoko, Karita, E., Kayitenkore, K., Omosa-Manyonyi, G., Allen, S., Than, S., Adams, E., Graham, B., Koup, R., Bailer, R., Smith, C., Dally, L., Farah, B., Anzala, O., Muvunyi, C., Bizimana, J., Tarragona-Fiol, T., Bergin, P., Hayes, P., Ho, M., Loughran, K., and Komaroff, W., Safety and Immunogenicity Study of Multiclade HIV-1 Adeno-Viral Vector Vaccine Alone or as Boost Following a Multiclade HIV-1 DNA Vaccine in Africa, PLoS ONE, vol. 5, p. e12873, 2010.
L. Chang, Dowd, K., Mendoza, F., Saunders, J., Sitar, S., Plummer, S., Yamshchikov, G., Sarwar, U., Hu, Z., Enama, M., Bailer, R., Koup, R., Schwartz, R., Akahata, W., Nabel, G., Mascola, J., Pierson, T., Graham, B., Ledgerwood, J., and Team, T. V. R. C. 311 St, Safety and Tolerability of Chikungunya Virus-Like Particle Vaccine in Healthy Adults: A Phase 1 Dose-Escalation Trial, Lancet, vol. 384, pp. 2046-2052, 2014.